Literature DB >> 3162753

Human AML colony growth in serum-free culture.

M Salem1, R Delwel, I Touw, L Mahmoud, B Löwenberg.   

Abstract

Here we report experiments dealing with the development of a fully serum-free culture system for AML cell proliferation. A number of compounds were tested for the requirements of AML colony formation and DNA synthesis in vitro in an attempt to replace serum with an artificial mixture. The results indicate that bovine serum albumin (BSA, 15 mg/ml), cholesterol (7.8 micrograms/ml), transferrin (7.7 X 10(-6) M) and insulin (1 microgram/ml) were essential for AML cell proliferation. Linoleic acid, 2-mercaptoethanol and selenite contributed only moderately beneficial effects. This mixture obviated the need for adding exogenous fetal calf or horse serum to the cultures and permitted equivalent and frequently superior AML colony formation and DNA synthesis. This is the first serum-free culture method for human AML that may allow for in-vitro studies of the growth regulation by recombinant growth factors under exactly defined and standardized conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162753     DOI: 10.1016/0145-2126(88)90076-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Clonal growth and self-renewal of human myeloid leukemia cell lines (BRM and DD) in serum-free semi-solid culture.

Authors:  C Kiss
Journal:  Blut       Date:  1990-11

2.  Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.

Authors:  O Elbaz; L M Budel; H Hoogerbrugge; I P Touw; R Delwel; L A Mahmoud; B Löwenberg
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

3.  Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients.

Authors:  Kimberley Joanne Hatfield; Øystein Bruserud; Håkon Reikvam
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

4.  Clonal growth of human acute leukemia cells in serum-free methylcellulose medium.

Authors:  Z Chen; P Zou; Y You; Z Liu; J Xiang; D Yu
Journal:  J Tongji Med Univ       Date:  1999

5.  Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

Authors:  A Pinto; D Aldinucci; V Gattei; V Zagonel; G Tortora; A Budillon; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

6.  Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation.

Authors:  F Dong; C van Buitenen; K Pouwels; L H Hoefsloot; B Löwenberg; I P Touw
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.

Authors:  R Pieters; D R Huismans; A Leyva; A J Veerman
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

8.  Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.

Authors:  Øystein Bruserud; Håkon Reikvam; Hanne Fredly; Jørn Skavland; Karen-Marie Hagen; Tuyen Thy van Hoang; Annette K Brenner; Amir Kadi; Audrey Astori; Bjørn Tore Gjertsen; Frederic Pendino
Journal:  Oncotarget       Date:  2015-02-20

9.  Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells.

Authors:  Ina Nepstad; Kimberley Joanne Hatfield; Ida Sofie Grønningsæter; Elise Aasebø; Maria Hernandez-Valladares; Karen Marie Hagen; Kristin Paulsen Rye; Frode S Berven; Frode Selheim; Håkon Reikvam; Øystein Bruserud
Journal:  Signal Transduct Target Ther       Date:  2019-06-19

10.  Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism.

Authors:  Ina Nepstad; Håkon Reikvam; Annette K Brenner; Øystein Bruserud; Kimberley J Hatfield
Journal:  Int J Mol Sci       Date:  2018-01-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.